JPMorgan Chase & Co. decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,982,009 shares of the company's stock after selling 20,748 shares during the quarter. JPMorgan Chase & Co. owned about 1.23% of Cardinal Health worth $352,682,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently modified their holdings of CAH. Elo Mutual Pension Insurance Co grew its stake in Cardinal Health by 21.9% in the fourth quarter. Elo Mutual Pension Insurance Co now owns 26,272 shares of the company's stock valued at $3,107,000 after acquiring an additional 4,718 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Cardinal Health by 5.6% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 433,810 shares of the company's stock valued at $51,754,000 after purchasing an additional 23,140 shares during the period. Korea Investment CORP increased its stake in Cardinal Health by 3.0% during the 4th quarter. Korea Investment CORP now owns 166,127 shares of the company's stock valued at $19,648,000 after purchasing an additional 4,900 shares in the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new position in Cardinal Health during the fourth quarter worth $248,000. Finally, TrueMark Investments LLC raised its holdings in Cardinal Health by 14.1% during the fourth quarter. TrueMark Investments LLC now owns 3,583 shares of the company's stock worth $424,000 after buying an additional 444 shares during the last quarter. Institutional investors own 87.17% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently commented on CAH. Argus set a $148.00 target price on shares of Cardinal Health in a research report on Tuesday, February 4th. JPMorgan Chase & Co. increased their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Morgan Stanley raised their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, January 31st. Citigroup upped their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research report on Friday, January 10th. Finally, Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $140.14.
Get Our Latest Research Report on CAH
Cardinal Health Trading Down 1.5 %
Shares of NYSE CAH traded down $2.08 during midday trading on Thursday, hitting $136.59. 1,744,512 shares of the company's stock were exchanged, compared to its average volume of 2,387,200. The business's fifty day moving average price is $128.98 and its two-hundred day moving average price is $121.33. The company has a market cap of $33.00 billion, a price-to-earnings ratio of 25.48, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's payout ratio is currently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.